Norway, June 24 -- Essange Reagents ("Essange") and Gentian Diagnostics ("Gentian") are pleased to announce their intention to enter into a collaboration agreement. Under the partnership, Essange will contribute with its technology, materials, and intellectual property related to selected existing assays, while Gentian will allocate research and development resources to support the evaluation and development activities.The intended cooperation combines Essange's expertise in specialty immunology reagents with Gentian's capabilities in adapting assays for automated clinical chemistry platforms. Initially, the parties will focus on evaluating selected assay opportunities and exploring the transfer of existing technologies into scalable turbid...